One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Effect of Pharmacogenomic Testing for Drug-Gene Interactions on Medication Selection and Remission of Symptoms in Major Depressive DisorderThe PRIME Care Randomized Clinical Trial
David W. Oslin, MD; Kevin G. Lynch, PhD; Mei-Chiung Shih, PhD; et al.
doi : 10.1001/jama.2022.9805
July 12, 2022, Vol 328, No. 2, Pages 105-222
Effect of High-Flow Nasal Cannula Therapy vs Continuous Positive Airway Pressure Therapy on Liberation From Respiratory Support in Acutely Ill Children Admitted to Pediatric Critical Care UnitsA Randomized Clinical Trial
Padmanabhan Ramnarayan, MD; Alvin Richards-Belle, BSc; Laura Drikite, MSc; et al.
doi : 10.1001/jama.2022.9615
Trends in Adverse Event Rates in Hospitalized Patients, 2010-2019
Noel Eldridge, MS; Yun Wang, PhD; Mark Metersky, MD; et al.
doi : 10.1001/jama.2022.9600
Comparison of an Emoji-Based Visual Analog Scale With a Numeric Rating Scale for Pain Assessment
Shuhan He, MD; Angela Renne, BS; Dias Argandykov, MD; et al.
doi : 10.1001/jama.2022.7489
Association Between COVID-19 Booster Vaccination and Omicron Infection in a Highly Vaccinated Cohort of Players and Staff in the National Basketball Association
Caroline G. Tai, PhD, MPH; Lisa L. Maragakis, MD, MPH; Sarah Connolly, PhD, MPH; et al.
doi : 10.1001/jama.2022.9479
Spirituality in Serious Illness and Health
Tracy A. Balboni, MD, MPH; Tyler J. VanderWeele, PhD; Stephanie D. Doan-Soares, DrPH; et al.
doi : 10.1001/jama.2022.11086
Monkeypox in 2022—What Clinicians Need to Know
Jeannette Guarner, MD; Carlos del Rio, MD; Preeti N. Malani, MD, MSJ
doi : 10.1001/jama.2022.10802
Reducing SARS-CoV-2 in Shared Indoor Air
Deborah Dowell, MD, MPH; William G. Lindsley, PhD; John T. Brooks, MD
doi : 10.1001/jama.2022.9970
Measuring Performance of the Diagnostic Process
Helen Burstin, MD, MPH; Karen Cosby, MD
doi : 10.1001/jama.2022.10166
Pharmacogenomic Testing for Next-Step Antidepressant SelectionStill a Work in Progress
Dan V. Iosifescu, MD, MSc
doi : 10.1001/jama.2022.10018
Improvements in Hospital Adverse Event RatesAchieving Statistically Significant and Clinically Meaningful Results
William V. Padula, PhD; Peter J. Pronovost, MD, PhD
doi : 10.1001/jama.2022.10281
Chronic Abdominal Pain and Anemia in a 59-Year-Old Man
Takashi Oshima, MD; Kiyoshi Kinjo, MD, MS; Mitsuyo Kinjo, MD, MPH
doi : 10.1001/jama.2022.9194
Highlights From the 2022 Annual Meeting of the American Society of Clinical Oncology—Disparities in Clinical Trials, Mitigating Clinician Burnout, and Combination Treatments for Cancer
Melissa Suran, PhD, MSJ
doi : 10.1001/jama.2022.9241
COVID-19 mRNA Vaccine Booster During Pregnancy Increases Maternal and Fetal Antibodies
Jennifer Abbasi
doi : 10.1001/jama.2022.11145
Young Children Increasingly Ingest Melatonin, With Serious Outcomes
Bridget M. Kuehn, MSJ
doi : 10.1001/jama.2022.11156
Case Study: Engineered T Cells Shrank Pancreatic Cancer Tumors
Howard D. Larkin
doi : 10.1001/jama.2022.11439
Dual Anti-HIV Antibodies Provide Long-term Viral Suppression
Howard D. Larkin
doi : 10.1001/jama.2022.10930
Dissolving “Smart� Pacemaker Design for Temporary Heart Pacing
Howard D. Larkin
doi : 10.1001/jama.2022.11440
What Is Monkeypox?
Kristin Walter, MD, MS; Preeti N. Malani, MD, MSJ
doi : 10.1001/jama.2022.10259
Clinical Protection During the First Omicron Wave in Unvaccinated, Convalescent US Adults
Mars Stone, PhD; Eduard Grebe, PhD; Michael P. Busch, MD, PhD
doi : 10.1001/jama.2022.10332
Clinical Protection During the First Omicron Wave in Unvaccinated, Convalescent US Adults—Reply
Jennifer L. Alejo, MD; Martin A. Makary, MD, MPH; Dorry L. Segev, MD, PhD
doi : 10.1001/jama.2022.10335
Sublingual Dexmedetomidine vs Placebo and Acute Agitation Associated With Bipolar Disorder
Akiko Abe, MD; Yuma Takeda, MD; Hiroto Ishiki, MD
doi : 10.1001/jama.2022.8346
Sublingual Dexmedetomidine vs Placebo and Acute Agitation Associated With Bipolar Disorder
Phillip Harrison Henry, MD; Bezalel Dantz, MD
doi : 10.1001/jama.2022.8352
Sublingual Dexmedetomidine vs Placebo and Acute Agitation Associated With Bipolar Disorder—Reply
Sheldon H. Preskorn, MD; Robert Risinger, MD; Rishi Kakar, MD
doi : 10.1001/jama.2022.8349
Over-the-Counter Availability of Rescue Inhalers for Asthma
Kathleen R. May, MD; John J. Oppenheimer, MD; Stanley J. Szefler, MD
doi : 10.1001/jama.2022.8769
Over-the-Counter Availability of Rescue Inhalers for Asthma
Sarah E. Gray, MD; Valerie G. Press, MD, MPH
doi : 10.1001/jama.2022.8772
Over-the-Counter Availability of Rescue Inhalers for Asthma—Reply
William B. Feldman, MD, DPhil, MPH; Jerry Avorn, MD; Aaron S. Kesselheim, MD, JD, MPH
doi : 10.1001/jama.2022.8775
